169 related articles for article (PubMed ID: 38062230)
21. Prognostic significance of epithelial/stromal caveolin-1 expression in prostatic hyperplasia, high grade prostatic intraepithelial hyperplasia and prostatic carcinoma and its correlation with microvessel density.
Mohammed DA; Helal DS
J Egypt Natl Canc Inst; 2017 Mar; 29(1):25-31. PubMed ID: 28259631
[TBL] [Abstract][Full Text] [Related]
22. Integrative exploration of the mutual gene signatures and immune microenvironment between benign prostate hyperplasia and castration-resistant prostate cancer.
Wu F; Ning H; Sun Y; Wu H; Lyu J
Aging Male; 2023 Dec; 26(1):2183947. PubMed ID: 36974949
[TBL] [Abstract][Full Text] [Related]
23. Do the expressions of epithelial-mesenchymal transition proteins, periostin, integrin-α4 and fibronectin correlate with clinico-pathological features and prognosis of metastatic castration-resistant prostate cancer?
Konac E; Kiliccioglu I; Sogutdelen E; Dikmen AU; Albayrak G; Bilen CY
Exp Biol Med (Maywood); 2017 Dec; 242(18):1795-1801. PubMed ID: 28836852
[TBL] [Abstract][Full Text] [Related]
24. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
25. Pretreatment Serum Cystatin C Levels Predict Renal Function, but Not Tumor Characteristics, in Patients with Prostate Neoplasia.
Yang F; Li D; Di Y; Zhang Y; Zang Y; Ren J; Yan L; Zhou Z; Liu H; Xu Z
Biomed Res Int; 2017; 2017():7450459. PubMed ID: 28812020
[TBL] [Abstract][Full Text] [Related]
26. Evaluation of Matrix Metalloproteases by Artificial Intelligence Techniques in Negative Biopsies as New Diagnostic Strategy in Prostate Cancer.
Eiro N; Medina A; Gonzalez LO; Fraile M; Palacios A; Escaf S; Fernández-Gómez JM; Vizoso FJ
Int J Mol Sci; 2023 Apr; 24(8):. PubMed ID: 37108185
[TBL] [Abstract][Full Text] [Related]
27. Human telomerase reverse transcriptase expression correlates with vascular endothelial growth factor-promoted tumor cell proliferation in prostate cancer.
Tang J; Wang Z; Li X; Li J; Shi H
Artif Cells Blood Substit Immobil Biotechnol; 2008; 36(2):83-93. PubMed ID: 18437586
[TBL] [Abstract][Full Text] [Related]
28. Infiltrating CD4+ T cells attenuate chemotherapy sensitivity in prostate cancer via CCL5 signaling.
Xiang P; Jin S; Yang Y; Sheng J; He Q; Song Y; Yu W; Hu S; Jin J
Prostate; 2019 Jun; 79(9):1018-1031. PubMed ID: 31018021
[TBL] [Abstract][Full Text] [Related]
29. Differential up-regulation of erythropoietin and its receptor in benign and malignant prostatic tissue.
Xu C; Zhou T; He M; Sun Y
Urol Oncol; 2010; 28(3):314-9. PubMed ID: 19070519
[TBL] [Abstract][Full Text] [Related]
30. [Expression of the epithelial cell adhesion molecule in prostate cancer and its clinical significance].
Li ZL; Jin RS
Zhonghua Nan Ke Xue; 2015 Apr; 21(4):320-4. PubMed ID: 26027098
[TBL] [Abstract][Full Text] [Related]
31. Differential display code 3 (DD3/PCA3) in prostate cancer diagnosis.
Klecka J; Holubec L; Pesta M; Topolcan O; Hora M; Eret V; Finek J; Chottova-Dvorakova M; Babjuk M; Novak K; Stolz J
Anticancer Res; 2010 Feb; 30(2):665-70. PubMed ID: 20332487
[TBL] [Abstract][Full Text] [Related]
32. Co-expression of TLR-9 and MMP-13 is associated with the degree of tumour differentiation in prostate cancer.
Kalantari E; Abolhasani M; Roudi R; Farajollahi MM; Farhad S; Madjd Z; Askarian-Amiri S; Mohsenzadegan M
Int J Exp Pathol; 2019 Apr; 100(2):123-132. PubMed ID: 31090157
[TBL] [Abstract][Full Text] [Related]
33. Single-cell analysis of localized prostate cancer patients links high Gleason score with an immunosuppressive profile.
Adorno Febles VR; Hao Y; Ahsan A; Wu J; Qian Y; Zhong H; Loeb S; Makarov DV; Lepor H; Wysock J; Taneja SS; Huang WC; Becker DJ; Balar AV; Melamed J; Deng FM; Ren Q; Kufe D; Wong KK; Adeegbe DO; Deng J; Wise DR
Prostate; 2023 Jun; 83(9):840-849. PubMed ID: 36988342
[TBL] [Abstract][Full Text] [Related]
34. Comparison of prostate cancer gene 3 score, prostate health index and percentage free prostate-specific antigen for differentiating histological inflammation from prostate cancer and other non-neoplastic alterations of the prostate at initial biopsy.
De Luca S; Passera R; Bollito E; Manfredi M; Scarpa RM; Sottile A; Randone DF; Porpiglia F
Anticancer Res; 2014 Dec; 34(12):7159-65. PubMed ID: 25503144
[TBL] [Abstract][Full Text] [Related]
35. Identification of immune cell infiltration pattern and related critical genes in metastatic castration-resistant prostate cancer by bioinformatics analysis.
Fan C; Lu W; Li K; Zhao C; Wang F; Ding G; Wang J
Cancer Biomark; 2021; 32(3):363-377. PubMed ID: 34151837
[TBL] [Abstract][Full Text] [Related]
36. Nucleolar and AgNOR-analysis of prostatic intraepithelial neoplasia (PIN), atypical adenomatous hyperplasia (AAH) and prostatic carcinoma.
Helpap B; Riede C
Pathol Res Pract; 1995 Jun; 191(5):381-90. PubMed ID: 7479355
[TBL] [Abstract][Full Text] [Related]
37. Intraepithelial Attack Rather than Intratumorally Infiltration of CD8+T Lymphocytes is a Favorable Prognostic Indicator in Pancreatic Ductal Adenocarcinoma.
Zhang J; Wang YF; Wu B; Zhong ZX; Wang KX; Yang LQ; Wang YQ; Li YQ; Gao J; Li ZS
Curr Mol Med; 2017; 17(10):689-698. PubMed ID: 29521231
[TBL] [Abstract][Full Text] [Related]
38. Differential expression of Low density lipoprotein Receptor-related Protein 1 (LRP-1) and matrix metalloproteinase-9 (MMP-9) in prostate gland: From normal to malignant lesions.
Gilardoni MB; Remedi MM; Oviedo M; Dellavedova T; Sarría JP; Racca L; Dominguez M; Pellizas CG; Donadio AC
Pathol Res Pract; 2017 Jan; 213(1):66-71. PubMed ID: 27931798
[TBL] [Abstract][Full Text] [Related]
39. Differential alterations in 5alpha-reductase type 1 and type 2 levels during development and progression of prostate cancer.
Thomas LN; Lazier CB; Gupta R; Norman RW; Troyer DA; O'Brien SP; Rittmaster RS
Prostate; 2005 May; 63(3):231-9. PubMed ID: 15538746
[TBL] [Abstract][Full Text] [Related]
40. CHRDL1, NEFH, TAGLN and SYNM as novel diagnostic biomarkers of benign prostatic hyperplasia and prostate cancer.
Su Z; Wang G; Li L
Cancer Biomark; 2023; 38(2):143-159. PubMed ID: 37781794
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
